Cancer and Tumor Development: Biomedical Background.- Cell-Cycle Specific Cancer Chemotherapy for Homogeneous Tumors.- Cancer Chemotherapy for Heterogeneous Tumor Cell Populations and Drug Resistance.- Optimal Control for Problems with a Quadratic Cost Functional on the Therapeutic Agents.- Optimal Control of Mathematical Models for Antiangiogenic Treatments.- Robust Suboptimal Treatment Protocols for Antiangiogenic Therapy.- Combination Therapies with Antiangiogenic Treatments.- Optimal Control for Mathematical Models of Tumor Immune System Interactions.- Concluding Remarks.- Appendices.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.